Sarclisa 100 MG per 5 ML Injection

RxCUI
2282028
RxNorm name
Sarclisa 100 MG per 5 ML Injection
Display name
Sarclisa 100 MG per 5 ML Injection
Full name
Sarclisa 100 MG per 5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761113Sarclisaisatuximab-irfc351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SarclisaISATUXIMABSanofi-Aventis U.S. LLCa0473462-6f9d-4eca-a5bf-8620aea68e8a2026-07-07Warnings, Adverse reactionsExact identifier
rxcui: 2282028

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a0473462-6f9d-4eca-a5bf-8620aea68e8aSarclisa 100 MG per 5 ML InjectionSY17These highlights do not include all the information needed to use SARCLISA safely and effectively. See full prescribing information for SARCLISA. SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 202020250616
a0473462-6f9d-4eca-a5bf-8620aea68e8a5 ML isatuximab-irfc 20 MG/ML Injection [Sarclisa]SBD17These highlights do not include all the information needed to use SARCLISA safely and effectively. See full prescribing information for SARCLISA. SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 202020250616
a0473462-6f9d-4eca-a5bf-8620aea68e8aSARCLISA 100 MG in 5 ML InjectionPSN17These highlights do not include all the information needed to use SARCLISA safely and effectively. See full prescribing information for SARCLISA. SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 202020250616
a0473462-6f9d-4eca-a5bf-8620aea68e8a5 ML Sarclisa 20 MG/ML InjectionSY17These highlights do not include all the information needed to use SARCLISA safely and effectively. See full prescribing information for SARCLISA. SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 202020250616